Provectus Biopharmaceuticals Return on Net Operating Assets Insights

Provectus Biopharmaceuticals, Inc. (PVCT)

0.0459 0.00 (0.00%) USD | OTCM | Feb 20, 15:21

View Return on Net Operating Assets for PVCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade
Imunon, Inc.	Upgrade

Upgrade